EXPLORE THE SCIENCE
TL;DR: A 2026 study in European Archives of Psychiatry and Clinical Neuroscience linked sustained quetiapine treatment with better high-working-memory cognitive performance in schizophrenia spectrum disorder, but the genetic tests did not support the proposed…
Read article
TL;DR: A 2026 case study in Biomedical Reports described a 28-year-old woman with bipolar II disorder whose stable subclinical counting compulsion worsened and expanded into new obsessive-compulsive symptoms within 3 days of starting cariprazine, then returned…
Read article
TL;DR: A 2026 claims analysis in Exploratory Research in Clinical and Social Pharmacy found that FDA-declared first-generation antipsychotic shortages were followed by medication switching in 9.13% of included patients with psychotic spectrum disorders, with e…
Read article
TL;DR: A 2026 network meta-analysis in International Clinical Psychopharmacology found that lurasidone and xanomeline-trospium improved global cognitive scores in schizophrenia-spectrum randomized trials, while quetiapine and cariprazine ranked best for attent…
Read article
TL;DR: A 2026 study in Health Science Reports found that metoclopramide and several antipsychotics were strongly overrepresented in FDA adverse-event reports for drug-induced dystonia, with many reported cases appearing within the first month after drug initia…
Read article
TL;DR: A 2026 study in BMC Psychiatry used Taiwan insurance records to find that dementia in people with schizophrenia was tied more strongly to age and linked medical comorbidities than to antipsychotic exposure after multivariable adjustment. Key Findings 14…
Read article
TL;DR: A 2026 Molecular Psychiatry ENIGMA mega-analysis found that medication status in bipolar disorder was linked to subtle differences in subcortical brain volume, with antiepileptic and antipsychotic exposure most consistently tied to smaller hippocampal a…
Read article
TL;DR: A 2026 population-based matched cohort study in British Journal of Psychiatry found that risperidone use was associated with increased stroke risk, adjusted hazard ratio 1.28, while absolute stroke incidence was especially high in people with prior stro…
Read article
TL;DR: A 2026 case study in Neurological Sciences described 2 Tourette syndrome patients who developed oculogyric crisis, a sustained upward eye-rolling dystonia, after aripiprazole was increased to 20-30 mg/day, with both cases resolving after dose reduction.…
Read article
TL;DR: A 2026 study in Drug Design, Development and Therapy validated liquid chromatography-tandem mass spectrometry (LC-MS/MS), a high-specificity lab method, to screen serum for 77 neuropsychiatric drugs and then applied it to 1,021 clinical specimens over 3…
Read article